Von Willebrand Factor (VWF) antibody

Details for Product No. ABIN93857
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Antigen
Synonyms F8VWF, VWD, AI551257, C630030D09, 6820430P06Rik, B130011O06Rik, VWF, si:ch1073-474e24.1
Reactivity
Human
(169), (58), (48), (43), (36), (26), (2), (2)
Host
Mouse
(90), (56), (39), (16), (1)
Clonality (Clone)
Monoclonal ()
Conjugate
Un-conjugated
(17), (12), (11), (3), (3), (3), (3), (3), (3), (3), (3), (1), (1)
Application
Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
(84), (78), (69), (49), (34), (30), (28), (21), (13), (11), (9), (8), (5), (5), (3), (3), (1), (1), (1)
Pubmed 5 references available
Catalog no. ABIN93857
Quantity 5 mL
Price
272.25 $   Plus shipping costs $45.00
Shipping to (Change)
Availability Will be delivered in 4 to 5 Business Days

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Immunogen Purified von-Willebrand-Factor isolated from human plasma
Clone F8-86
Isotype IgG1
Specificity Human von-Willebrand-Factor, Factor VIII related Antigen
Alternative Name Von-Willebrand-Factor
Research Area Coagulation
Application Notes IHC(C, P) , Pre-treatment with pronase 0.1% . neat Positive Control: Appendix
Restrictions For Research Use only
Format Liquid
Buffer stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide. The volume is sufficient for at least 100 immunohistochemical tests (100 ul working solution / test)
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage 4 °C
General Hruban, Kuhajda, Mann: "Acute myelofibrosis. Immunohistochemical study of four cases and comparison with acute megakaryocytic leukemia." in: American journal of clinical pathology, Vol. 88, Issue 5, pp. 578-88, 1987 (PubMed).

Yang, Lecksell, Gaudin et al.: "Rare expression of high-molecular-weight cytokeratin in adenocarcinoma of the prostate gland: a study of 100 cases of metastatic and locally advanced prostate cancer." in: The American journal of surgical pathology, Vol. 23, Issue 2, pp. 147-52, 1999 (PubMed).

Signoretti, Waltregny, Dilks et al.: "p63 is a prostate basal cell marker and is required for prostate development." in: The American journal of pathology, Vol. 157, Issue 6, pp. 1769-75, 2000 (PubMed).

Weinstein MH, Signoretti S, Loda M: "Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells." in: Mod Pathol, Vol. 15, Issue 12, pp. 1302-8, 2002 (PubMed).

Browne TJ, Hirsch MS, Brodsky G et al.: "Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens." in: Hum Pathol, Vol. 35, Issue 12, pp. 1462-8, 2004 (PubMed).

Hosts (90), (56), (39), (16), (1)
Reactivities (169), (58), (48), (43), (36), (26), (2), (2)
Applications (84), (78), (69), (49), (34), (30), (28), (21), (13), (11), (9), (8), (5), (5), (3), (3), (1), (1), (1)
Conjugates (17), (12), (11), (3), (3), (3), (3), (3), (3), (3), (3), (1), (1)
Epitopes (4), (4), (2), (2), (1), (1), (1), (1)
Request Want additional data for this product?

The Independent Validation Initiative strives to provide you with high quality data. Find out more

Order hotline:

  • +1 404 474 4654
  • +1 888 205 9894 (TF)
Validation Images
back to top